To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
RespimatRespimat, or commonly referred to as Respimat SMI, with the SMI acronym to mean, Soft Mist Inhaler. Additional recommended knowledgeRespimat SMI is an advanced drug delivery device in comparison to MDIs or DPIs used for the treatment of Asthma, COPD, and other respiratory conditions. Its developer, Boehringer Ingelheim, is currently conducting Phase III clinical trials in the US with a variety of their products, such as Spiriva and Combivent.
SourcesBoehinger-Ingelheim information Respimat Home |
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Respimat". A list of authors is available in Wikipedia. |